Trend in approval of targeted biologics in the last two decades
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.
Hoofdauteur: | Siddika, Khadiza |
---|---|
Andere auteurs: | Ahmed, Syeda Maliha |
Formaat: | Thesis |
Taal: | English |
Gepubliceerd in: |
Brac University
2024
|
Onderwerpen: | |
Online toegang: | http://hdl.handle.net/10361/24296 |
Gelijkaardige items
-
Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022) -
Study on anticancer drugs approved by the FDA from 2014 to 2023
door: Rattry, Faria Rahman
Gepubliceerd in: (2024) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023) -
RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024) -
Molecular biology : genes to proteins /
door: Tropp, Burton E.
Gepubliceerd in: (2008)